FDA chief: COVID, mail mix-up delayed action on baby formula

WASHINGTON (AP) — The head of the Food and Drug Administration said Wednesday that efforts to investigate problems at a baby formula plant linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and even a missing piece of mail.

Read more…

Please follow and like us: